Report Highlights
The global market for sleep aids and technologies is expected to reach $84.9 billion by 2021 from $66.3 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.1% from 2016 through 2021.
Report Includes
- An overview of the global market for sleep aids and related technologies.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
- Identification of the different disorders that manifest with sleep disorder symptoms.
- Information on different methods used to enhance sleep including medications, devices, and laboratories.
- Details on emerging technologies and developing trends.
- A look at the market's dynamics including growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.
Report Scope
This report primarily focuses on the following sleep disorders:
- Insomnia.
- Sleep apnea.
- RLS.
- Bruxism.
- Narcolepsy.
- Sleepwalking.
The report discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the market soon. Analyses are provided for each of the key companies in the major and minor market segments. The sleep aids and diagnostic centers discussed in this report include:
- Medications.
- Prescriptions.
- Over-the-counter (OTC).
- Herbal remedies.
- Sleep laboratories.
- Sleep apnea devices.
- Mattresses and pillows.
All markets are further broken down into specific types of products that are discussed in detail, measuring current and potential market size, identifying current and potential market drivers, detailing the markets from 2015, 2016 and 2021 and assessing the competitors in the market and their respective shares in various market segments.
Analyst Credentials
Natana Raj is a medical analyst and has edited more than two dozen market research reports in the past eight years, covering pharmaceuticals, medical devices, stem cells and beverages. He is a retired college professor with 32 years of experience in teaching biochemistry, biotechnology, biochemical pharmacology, molecular biology and genetics. In addition to a Master of Science degree, he also holds diplomas in biochemistry, biochemical pharmacology, biotechnology and environmental biology.
Report Highlights
The global market for sleep aids totaled $54.9 billion in 2013. This market is estimated to grow at a compound annual growth rate (CAGR) of 5.6% to reach $58.5 billion in 2014 and $76.7 billion by 2019.
Report Includes
- An overview of the global market for sleep aids and related technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Identification of the different disorders that manifest with sleep disorder symptoms.
- Information on different methods used to enhance sleep including medications, devices, and laboratories.
- Details on emerging technologies and developing trends.
Report Highlights
-
The worldwide sleep aids markets reached revenues of $25 billion in 2009. Revenues are anticipated to reach $33.2 billion in 2014, growing at a compound annual growth rate (CAGR) of 5.8% over the forecast period of 2009 to 2014.
-
The largest market in terms of annual revenues is the mattresses and pillows segment, but it is currently the slowest growing of all the markets. This segment was worth $10.6 billion in 2009 and is expected to reach $12.5 billion by 2015, a compound annual growth rate (CAGR) of 3.3%.
-
The second-largest market is sleep laboratories, with revenues of $6.7 billion in 2009. This segment is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach $9.2 billion in 2014.
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Continuous Positive Airway Pressure (CPAP) Devices: Global Markets
The global market for CPAP devices market should grow from $3.3 billion in 2019 to $4.5 billion by 2024, at a compound annual growth rate (CAGR) of 6.2% for the period of 2019-2024.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More